Incannex Healthcare Files S-1/A Amendment

TL;DR

INCX S-1/A filed - looks like they're raising capital.

AI Summary

Incannex Healthcare Inc. filed an S-1/A amendment on November 26, 2024, for its registration statement (No. 333-283025). The company, incorporated in Delaware, is in the Pharmaceutical Preparations industry and is seeking to register securities. Joel Latham is listed as the Chief Executive Officer and President.

Why It Matters

This filing indicates Incannex Healthcare Inc. is moving forward with a public offering of its securities, which could provide capital for its pharmaceutical development activities.

Risk Assessment

Risk Level: medium — S-1 filings generally indicate a company is seeking to raise capital through a public offering, which carries inherent market and execution risks.

Key Numbers

• 333-283025 — Registration Statement Number (Identifies the specific SEC filing for Incannex Healthcare Inc.)
• 2834 — SIC Code (Indicates the company operates in the Pharmaceutical Preparations industry.)

Key Players & Entities

• Incannex Healthcare Inc. (company) — Registrant
• 333-283025 (dollar_amount) — Registration Statement Number
• November 26, 2024 (date) — Filing Date
• Joel Latham (person) — CEO and President
• 2834 (dollar_amount) — Standard Industrial Classification Code

FAQ

Key Financial Figures

• $0.0001 — ares”) of common stock, par value $0.0001 per share, of Incannex Healthcare Inc.
• $50.0 million — t”) relating to the sale of up to $50.0 million of Common Stock, (ii) up to 250,000 sha
• $3.0 million — Purchase Agreement and we have received $3.0 million of gross proceeds in respect of the Fir
• $2.09 — price of the Common Stock on Nasdaq was $2.09 per share. Investing in our Common St
• $1.235 billion — e Act, our annual gross revenues exceed $1.235 billion or we issue more than $1.0 billion of n
• $1.0 billion — ed $1.235 billion or we issue more than $1.0 billion of non-convertible debt in any three-ye
• $250.0 million — ock held by non-affiliates is less than $250.0 million measured on the last business day of ou
• $100.0 million — ter, or our annual revenue is less than $100.0 million during the most recently completed fisc
• $700.0 million — ock held by non-affiliates is less than $700.0 million measured on the last business day of ou
• $20.04 — ng a weighted average exercise price of $20.04 per share; 3,464,344 shares of Common
• $0.33 — price, all subject to a floor price of $0.33 per share. Accordingly, the exact numbe

Filing Documents

• ea0222518-s1a1_incannex.htm (S-1/A) — 392KB
• ea022251801ex5-1_incannex.htm (EX-5.1) — 15KB
• ea022251801ex23-1_incannex.htm (EX-23.1) — 2KB
• ea022251801ex-fee_incannex.htm (EX-FILING FEES) — 12KB
• image_001.jpg (GRAPHIC) — 6KB
• image_002.jpg (GRAPHIC) — 6KB
• ex5-1_001.jpg (GRAPHIC) — 2KB
• ex5-1_002.jpg (GRAPHIC) — 2KB
• 0001213900-24-102808.txt ( ) — 444KB

RISK FACTORS

RISK FACTORS 4 SPECIAL NOTE REGARDING FORWARD-LOOKING INFORMATION 6 DESCRIPTION OF THE TRANSACTIONS 7

USE OF PROCEEDS

USE OF PROCEEDS 12 DIVIDEND POLICY 12 SELLING STOCKHOLDERS 13

DESCRIPTION OF CAPITAL STOCK

DESCRIPTION OF CAPITAL STOCK 14 PLAN OF DISTRIBUTION 20 EXPERTS 21 LEGAL MATTERS 21 WHERE YOU CAN FIND MORE INFORMATION 21 INCORPORATION OF CERTAIN INFORMATION BY REFERENCE 22 i ABOUT THIS PROSPECTUS This prospectus is part of a registration statement on Form S-1 that we have filed with the Securities and Exchange Commission (the “SEC”) pursuant to which the selling stockholders named herein may, from time to time, offer and sell or otherwise dispose of the Shares covered by this prospectus. You should not assume that the information contained in this prospectus is accurate on any date subsequent to the date set forth on the front cover of this prospectus or that any information we have incorporated by reference is correct on any date subsequent to the date of the document incorporated by reference, even though this prospectus is delivered or Shares are sold or otherwise disposed of on a later date. This prospectus does not contain all of the information included in the registration statement. For a more complete understanding of the offering of the Shares, you should refer to the registration statement including the exhibits. Copies of some of the documents referred to herein have been filed, will be filed or will be incorporated by reference as exhibits to the registration statement of which this prospectus is a part, and you may obtain copies of those documents as described below under the heading “Where You Can Find More Information.” This prospectus contains summaries of certain provisions contained in some of the documents described herein, or that are filed, will be filed or will be incorporated by reference as exhibits to the registration statement of which this prospectus is a part, but reference is made to the actual documents for complete information. All of the summaries are qualified in their entirety by the actual documents. We further note that the representations, warranties and covenants made by u

View Full Filing

View this S-1/A filing on SEC EDGAR